BiotechTube
Home/MDI Therapeutics/Daniel A. Lawrence, PhD
DA

Daniel A. Lawrence, PhD

Founder, Chairman of Clinical & Scientific Advisory Board

MDI Therapeutics

Therapeutic Areas

FibrosisFibroproliferative Diseases

MDI Therapeutics Pipeline

DrugIndicationPhase
Oral PAI-1 InhibitorFibrosis and Fibroproliferative DiseasesPreclinical

Leadership Team at MDI Therapeutics

GD
Gillian Dines
Chief Executive Officer
View full MDI Therapeutics profile